Michelle Griffin

Dr. Michelle Griffin

Academic Department of Surgery, University College London, Gower St, Bloomsbury, London WC1E 6BT, UK
+1

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
SMShamik Mascharak
Shamik Mascharak
HDHeather E. Desjardins-Park
Heather E. Desjardins-Park
MDMichael F. Davitt
Michael F. Davitt
MGMichelle Griffin
Michelle Griffin
MBMimi R Borrelli
Mimi R Borrelli
Michael T. LongakerMichael T. Longaker
Michael T. Longaker
Regeneration without scarring: Wounds in adult mammals typically heal by forming fibrotic scars. Mascharak et al. found that a specific population of skin fibroblasts ( Engrailed-1 lineage–negative fibroblasts) activate expression of Engrailed-1 and turn on profibrotic cellular programs in response to local tissue mechanics in wounds (see the Perspective by Konieczny and Naik). When mechanical signaling was inhibited in these cells (using either genetic deletion or small-molecule inhibition), skin wounds in mice no longer formed scars but instead healed by regeneration, restoring skin with normal hair follicles and glands, extracellular matrix, and mechanical strength. Science , this issue p. eaba2374 ; see also p. 346

24 January 2022 in Cell Stem Cell
Verified
Journal Article
Closed access
SMShamik Mascharak
Shamik Mascharak
HTHeather E. Talbott
Heather E. Talbott
MJMichael Januszyk
Michael Januszyk
MGMichelle Griffin
Michelle Griffin
KCKellen Chen
Kellen Chen
Michael T. LongakerMichael T. Longaker
Michael T. Longaker

28 February 2017 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JVJajini Varghese
Jajini Varghese
MGMichelle Griffin
Michelle Griffin
AMAfshin Mosahebi
Afshin Mosahebi
PBPeter Butler
Peter Butler
The applications for fat grafting have increased recently, within both regenerative and reconstructive surgery. Although fat harvesting, processing and injection techniques have been extensively studied and standardised, this has not had a big impact on the variability of outcome following fat grafting. This suggests a possible larger role of patient characteristics on adipocyte and adipose-derived stem cell (ADSC) viability and function. This systematic review aims to collate current evidence on the effect of patient factors on adipocyte and ADSC behaviour. A systematic literature review was performed using MEDLINE, Cochrane Library and EMBASE. It includes outcomes observed in in vitro analyses, in vivo animal studies and clinical studies. Data from basic science work have been included in the discussion to enhance our understanding of the mechanism behind ADSC behaviour. A total of 41 papers were included in this review. Accumulating evidence indicates decreased proliferation and differentiation potential of ADSCs with increasing age, body mass index, diabetes mellitus and exposure to radiotherapy and Tamoxifen, although this was not uniformly seen across all studies. Gender, donor site preference, HIV status and chemotherapy did not show a significant influence on fat retention. Circulating oestrogen levels have been shown to support both adipocyte function and graft viability. Evidence so far suggests no significant impact of total cholesterol, hypertension, renal disease, physical exercise and peripheral vascular disease on ADSC yield. A more uniform comparison of all factors highlighted in this review, with the application of a combination of tests for each outcome measure, is essential to fully understand factors that affect adipocyte and ADSC viability, as well as functionality. As these patient factors interact, future studies looking at adipocyte viability need to take them into consideration for conclusions to be meaningful. This would provide crucial information for surgeons when deciding appropriate volumes of lipoaspirate to inject, improve patient selection, and counsel patient expectations with regards to outcomes and likelihood for repeat procedures. An improved understanding will also assist in identification of patient groups that would benefit from graft enrichment and cryopreservation techniques.

1 September 2020 in International Journal of Surgery
Verified
Journal Article
Closed access
MNMaria Nicola
Maria Nicola
CSCatrin Sohrabi
Catrin Sohrabi
GMGinimol Mathew
Ginimol Mathew
AKAhmed Kerwan
Ahmed Kerwan
AAAhmed Al-Jabir
Ahmed Al-Jabir
RARiaz Agha
Riaz Agha
On March 11, 2020, the spread of the SARS-CoV-2 virus was declared a pandemic by the World Health Organization (WHO). Approximately 19.3 million people have now been infected and over 700,000 have died. This global public health crisis has since cascaded into a series of challenges for leaders around the world, threatening both the health and economy of populations. This paper attempts to compartmentalise leadership aspects, allowing a closer examination of published reports and the analysis of current outcomes, thus enabling the authors to formulate a number of evidence-based recommendations on the de-escalation of restrictions.

1 January 2018 in Journal of Surgical Education
Verified
Journal Article
Closed access
BLBenjamin J. Langridge
Benjamin J. Langridge
SMSheikh Momin
Sheikh Momin
BCBen Coumbe
Ben Coumbe
EWEvelina Woin
Evelina Woin
MGMichelle Griffin
Michelle Griffin
PBPeter Butler
Peter Butler

16 June 2020 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
MGMichelle Griffin
Michelle Griffin
Nathan CastroNathan Castro
Nathan Castro
OBOnur Bas
Onur Bas
SSSiamak Saifzadeh
Siamak Saifzadeh
PBPeter Butler
Peter Butler
Dietmar Werner HutmacherDietmar Werner Hutmacher
Dietmar Werner Hutmacher
Reconstructive surgery aims to restore tissue defects by replacing them with similar autologous tissue to achieve good clinical outcomes. However, often the defect is too large or the tissue available is limited, requiring synthetic materials to restore the anatomical shape and partial function. The utilization of three-dimensional (3D) printing allows for the manufacture of implants with complex geometries and internal architecture that more closely matches the required clinical needs. Synthetic polymers offer certain advantages over natural polymers as biomedical materials due to their ability to more closely mimic the mechanical and chemical properties of the native tissue. Synthetic polymer materials such as poly(lactic acid) and acrylonitrile butadiene styrene are easily 3D printed to generate 3D objects due to their flexibility in their chemical and mechanical properties and physical form. Polyurethanes (PUs) are widely used as short- and long-term, implantable medical devices due to their good mechanical properties, biocompatibility, and hemocompatibility. This article provides an overview on the advancement of 3D printable PU-based materials for biomedical applications. A summary of the chemical structure and synthesis of PUs is provided to explain how PUs may be processed into medical devices using additive manufacturing techniques. Currently, PUs are being explored by several 3D printing approaches, including fused filament fabrication, bioplotting, and stereolithography, to fabricate complex implants with precise patterns and shapes with fine resolution. PU scaffolds using 3D printing have shown good cell viability and tissue integration in vivo . The important limitations of PU printing are identified to stimulate future research. PUs offer a biocompatible, synthetic polymeric material that can be 3D printed to manufacture implants that are tailored to meet specific anatomical, mechanical, and biological requirements for biomedical applications.